Clinical Trials Logo

Chest Wall Tumor clinical trials

View clinical trials related to Chest Wall Tumor.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05369234 Recruiting - Esophageal Cancer Clinical Trials

Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis

Start date: January 20, 2022
Phase: Phase 3
Study type: Interventional

As mentioned above, several prior studies have shown the positive effects of oral use of aloe vera juice in managing chemotherapy and radiation-induced oral mucositis and esophagitis. This study aims to add to the existing body of research around aloe vera juice and its effects on oral mucositis and esophagitis. The intention is to determine whether aloe vera juice should be considered as part of standard treatment.

NCT ID: NCT05057143 Recruiting - Surgery Clinical Trials

3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors

Start date: January 10, 2022
Phase: N/A
Study type: Interventional

A patient with a tumor lesion of the chest wall undergoes CT scan with a step width of less than 1 mm, then engineers design an individual model to replace the defect. Using a 3D printer, a model is made based on titanium alloy powder. Preoperative preparation takes an average of 14-21 days. The next stage is surgical treatment in the amount of resection of the chest wall with plastic defect with an individual titanium implant. In some cases, the titanium framework is separated from the pleural cavity by a polytetrafluoroethylene plate in order to seal and prevent the development of pulmonary hernias. The advantages of titanium individual prostheses include accurate matching of the implant to the size and characteristics of the defect, individual modeling allows you to repeat the anatomical features of the patient. This method helps to recreate the original shape of the chest, and most importantly, symmetrical, relatively healthy half. With the help of titanium, individualized prostheses are made based on 3D modeling, which will reduce the incidence of complications, accelerate rehabilitation and improve the quality of life of patients with tumor lesions of the chest wall. The postoperative period takes 15-30 days.

NCT ID: NCT04077710 Recruiting - Chest Wall Tumor Clinical Trials

RISI in the Treatment of Recurrent Chest Wall Malignancies After EBRT

Start date: May 1, 2020
Phase:
Study type: Observational

This study will observe the efficacy and toxicities of 3-dimensional printing noncoplanar template assisted CT guided radioactive iodine-125 seeds implantation in the treatment of patients with recurrent chest wall malignancies after external beam radiotherapy prospectively, and analyzes the influence of clinical and dosimetric factors on the outcomes.